ACET Stock Price
Adicet Bio, Inc.
ACET stock price is $4.89 (-4.31% on the day), giving Adicet Bio, Inc. a market cap of $45.78M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
ACET Stock Overview
- Price
- $4.89
- Previous close
- $5.11
- Open
- $5.10
- Market cap
- $45.78M
- P/E ratio
- -0.4
- 52-week range
- $5.55 - $17.44
- 1-year price target
- $34.83
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Exchange
- NSC
- MarketXLS Rank
- 33
About Adicet Bio, Inc.
Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. It offers gamma delta T cells engineered with chimeric antigen receptors (CARs) to facilitate durable activity in patients. The company's lead product candidate is ADI-001, an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, which is in Phase I clinical trial for the potential treatment of autoimmune diseases and relapsed/refractory B-cell non-hodgkin's lymphoma. It also develops ADI-270, an armored gamma delta CAR T cell product candidate to treat multiple CD70+ solid tumor and hematological malignancies indications, with renal cell carcinoma. The company was founded in 2014 and is based in Boston, Massachusetts.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ACET | $4.89 | -4.3% | 357.76K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |